These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

727 related items for PubMed ID: 16573259

  • 1. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
    Tanghetti E, Abramovits W, Solomon B, Loven K, Shalita A.
    J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
    [Abstract] [Full Text] [Related]

  • 2. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E, Dhawan S, Torok H, Kircik L.
    Dermatol Online J; 2007 Jul 13; 13(3):1. PubMed ID: 18328195
    [Abstract] [Full Text] [Related]

  • 3. Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
    Draelos ZD, Tanghetti EA, Tazarotene Combination Leads to Efficacious Acne Results (CLEAR) Trial Study Group.
    Cutis; 2002 Feb 13; 69(2 Suppl):20-9. PubMed ID: 12095065
    [Abstract] [Full Text] [Related]

  • 4. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, Shupack J.
    Arch Dermatol; 2006 May 13; 142(5):605-12. PubMed ID: 16702498
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea.
    Breneman D, Savin R, VandePol C, Vamvakias G, Levy S, Leyden J.
    Int J Dermatol; 2004 May 13; 43(5):381-7. PubMed ID: 15117375
    [Abstract] [Full Text] [Related]

  • 6. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR, Tazarotene Cream in Acne Clinical Study Investigator Group.
    Clin Ther; 2004 Nov 13; 26(11):1865-73. PubMed ID: 15639698
    [Abstract] [Full Text] [Related]

  • 7. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
    Bowman S, Gold M, Nasir A, Vamvakias G.
    J Drugs Dermatol; 2005 Nov 13; 4(5):611-8. PubMed ID: 16167420
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF, Alió Sáenz AB.
    J Drugs Dermatol; 2011 Dec 13; 10(12):1382-96. PubMed ID: 22134562
    [Abstract] [Full Text] [Related]

  • 9. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
    Tanghetti E, Kircik L, Wilson D, Dhawan S.
    J Drugs Dermatol; 2008 Jun 13; 7(6):534-8. PubMed ID: 18561583
    [Abstract] [Full Text] [Related]

  • 10. Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
    Shalita A.
    Cutis; 2004 Oct 13; 74(4 Suppl):4-8. PubMed ID: 15543713
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
    Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, Kasteler JS, Kircik L, Oefelein MG, Draelos Z.
    J Drugs Dermatol; 2011 Jul 13; 10(7):783-92. PubMed ID: 21720661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.